Vident Investment Advisory LLC Purchases 1,440 Shares of Colgate-Palmolive (CL)

Vident Investment Advisory LLC increased its position in shares of Colgate-Palmolive (NYSE:CL) by 12.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,231 shares of the company’s stock after acquiring an additional 1,440 shares during the period. Vident Investment Advisory LLC’s holdings in Colgate-Palmolive were worth $998,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Renaissance Technologies LLC increased its position in Colgate-Palmolive by 42.4% during the second quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after buying an additional 2,903,800 shares during the last quarter. APG Asset Management N.V. increased its position in Colgate-Palmolive by 243.0% during the third quarter. APG Asset Management N.V. now owns 4,070,784 shares of the company’s stock worth $296,557,000 after buying an additional 2,884,100 shares during the last quarter. Harding Loevner LP increased its position in Colgate-Palmolive by 92.0% during the third quarter. Harding Loevner LP now owns 4,742,752 shares of the company’s stock worth $176,329,000 after buying an additional 2,272,675 shares during the last quarter. First Eagle Investment Management LLC increased its position in Colgate-Palmolive by 35.8% during the third quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock worth $483,837,000 after buying an additional 1,750,417 shares during the last quarter. Finally, Vanguard Group Inc. increased its position in Colgate-Palmolive by 2.4% during the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after buying an additional 1,621,392 shares during the last quarter. Institutional investors and hedge funds own 73.64% of the company’s stock.

How to Become a New Pot Stock Millionaire

Colgate-Palmolive stock opened at $68.69 on Thursday. The company has a market cap of $61,001.52, a PE ratio of 30.13, a price-to-earnings-growth ratio of 2.58 and a beta of 0.79. The company has a debt-to-equity ratio of 27.02, a quick ratio of 1.00 and a current ratio of 1.36. Colgate-Palmolive has a one year low of $68.19 and a one year high of $77.91.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The company had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same quarter in the previous year, the company posted $0.75 earnings per share. Colgate-Palmolive’s quarterly revenue was up 4.6% compared to the same quarter last year. equities analysts expect that Colgate-Palmolive will post 3.18 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be paid a $0.42 dividend. The ex-dividend date is Thursday, April 19th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.45%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. Colgate-Palmolive’s payout ratio is 70.18%.

Several equities analysts have commented on CL shares. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a research report on Tuesday, January 16th. Macquarie raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price on the stock in a research report on Tuesday, December 19th. Deutsche Bank started coverage on shares of Colgate-Palmolive in a research report on Wednesday, December 13th. They set a “hold” rating and a $75.00 target price on the stock. Finally, Societe Generale downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price on the stock. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and five have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $77.76.

In other news, insider Jennifer Daniels sold 902 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total value of $68,389.64. Following the completion of the transaction, the insider now owns 37,788 shares in the company, valued at $2,865,086.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CTO Patricia Verduin sold 1,572 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $70.17, for a total transaction of $110,307.24. Following the completion of the transaction, the chief technology officer now owns 50,675 shares of the company’s stock, valued at approximately $3,555,864.75. The disclosure for this sale can be found here. Insiders sold 455,707 shares of company stock valued at $32,443,427 in the last quarter. 1.02% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3289332/vident-investment-advisory-llc-purchases-1440-shares-of-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Enable Midstream Partners LP  Expected to Post Earnings of $0.22 Per Share
Enable Midstream Partners LP Expected to Post Earnings of $0.22 Per Share
Farmer Brothers  Expected to Post Quarterly Sales of $160.95 Million
Farmer Brothers Expected to Post Quarterly Sales of $160.95 Million
Brokerages Anticipate Tanger Factory Outlet Centers  Will Post Quarterly Sales of $117.95 Million
Brokerages Anticipate Tanger Factory Outlet Centers Will Post Quarterly Sales of $117.95 Million
Barclays Reaffirms Hold Rating for Webster Bank
Barclays Reaffirms Hold Rating for Webster Bank
Gazit Globe  and Getty Realty  Head to Head Survey
Gazit Globe and Getty Realty Head to Head Survey
RTI Surgical  & Coloplast  Critical Contrast
RTI Surgical & Coloplast Critical Contrast


© 2006-2018 Ticker Report. Google+.